All results
1 results for phase 2 clinical trial patients metastatic neuroblastoma bone
-
Neuroblastoma Maintenance Therapy Trial (NMTT)
Difluoromethylornithine (DFMO) will be used in an open label, single agent, multicenter, study for patients with neuroblastoma in remission. In this study…
- Ages
- 1 Year - 30 Years
- Sexes
- All